Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.62 |
| ▸ | ESR1 | P03372 | 4/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | ABAT | P80404 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL11578828 | 1.00 | IDO1 (0.62) | IDO1ESR1ESR2TSHRABAT | |
| Ethylene Glycol SCHEMBL7940749 | 0.92 | CA2 (0.56) | IDO1ESR1ESR2TSHRABAT | |
| SCHEMBL1840533 | 0.89 | TSHR (0.75) | IDO1ESR1ESR2TSHRCA2 | |
| SCHEMBL22853855 | 0.88 | IDO1 (0.56) | IDO1ESR1ESR2TSHRABAT | |
| Hydroquinone SCHEMBL51561 | 0.86 | TSHR (0.79) | IDO1TSHRCA2KDM4EALDH1A1 | |
| SCHEMBL2645635 | 0.86 | IDO1 (0.54) | IDO1ESR1ESR2TSHRABAT | |
| SCHEMBL7940753 | 0.86 | IDO1 (0.54) | IDO1ESR1ESR2TSHRABAT | |
| Biphenyl SCHEMBL11503485 | 0.85 | TSHR (0.61) | IDO1ESR1ESR2TSHRCA2 | |
| SCHEMBL15275219 | 0.84 | IDO1 (0.58) | IDO1ESR1ESR2TSHRABAT | |
| SCHEMBL21815364 | 0.84 | IDO1 (0.52) | IDO1ESR1ESR2TSHRABAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116854866-B | MMA (methyl methacrylate) bi-component unsaturated polyester resin for road coating and preparation method thereof | 浙江创赢新材料有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-117089842-A | Etching composition and application thereof | 晶瑞电子材料股份有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-116854866-A | MMA (methyl methacrylate) bi-component unsaturated polyester resin for road coating and preparation method thereof | 浙江创赢新材料有限公司 | 2023-10-10 | — | — | CN | claimed |
| CN-110343209-B | Bidentate phosphorus ligand polymer, preparation method thereof and application thereof in olefin hydroformylation reaction | 中国科学院青岛生物能源与过程研究所 | 2021-09-17 | — | — | CN | claimed |
| CN-111378311-A | UV putty with high light guide performance for plate processing and preparation method thereof | 泰州市龙洋木业有限公司 | 2020-07-07 | — | — | CN | claimed |
| EP-2657264-B1 | PREPARATION METHOD OF HYPERBRANCHED POLYCARBOXYLIC ACID TYPE COPOLYMER CEMENT DISPERSANT | SOBUTE NEW MATERIALS CO LTD (CN) | 2016-03-02 | — | — | EP | claimed |
| US-8580992-B1 | Compounds and methods of arylmethylation (benzylation) as protection for alcohol groups during chemical synthesis | The Florida State University Research Foundation, Inc. (US) | 2013-11-12 | — | — | US | claimed |
| US-20100256383-A1 | Compounds and Methods of Arylmethylation (Benzylation) As Protection For Alcohol Groups During Chemical Synthesis | DUDLEY GREGORY | 2010-10-07 | — | — | US | claimed |
| CN-119997386-A | Preparation process of ultralow dielectric constant circuit board | 开平依利安达电子第五有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119944100-A | Preparation method of semi-solid cylindrical battery with high-porosity composite pole piece | 固科亚太新能源科技(深圳)有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119821018-A | System and method for printing and drying fragrances and perfumes | 国际香料和香精公司 | 2025-04-15 | — | — | CN | disclosed |
| US-20250004316-A1 | ANTI-GLARE COMPOSITIONS, ANTI-GLARE FILMS, POLARIZERS, AND DISPLAY DEVICES | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2025-01-02 | — | — | US | disclosed |
| CN-117447948-A | Low-VOC (volatile organic compound) high-solid-content aqueous polyurethane adhesive and preparation method and application thereof | 华南理工大学 | 2024-01-26 | — | — | CN | disclosed |
| US-20230192760-A1 | SYSTEMS AND METHODS FOR TYROSINASE-MEDIATED SITE-SPECIFIC PROTEIN CONJUGATION | GENENTECH, INC. | 2023-06-22 | — | — | US | disclosed |
| EP-1155098-A1 | LIQUID CRYSTALLINE SUBSTANCE MIXTURES | BASF AKTIENGESELLSCHAFT (DE) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000047694-A1 | LIQUID CRYSTALLINE SUBSTANCE MIXTURES | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-17 | — | — | WO | disclosed |
| US-6080383-A | Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer | ROSE SAMUEL (US) | 2000-06-27 | — | — | US | disclosed |
| US-5816259-A | Method for the diagnosis and treatment of cancer by the accumulation of radioactive precipitates in targeted cells | ROSE SAMUEL (US) | 1998-10-06 | — | — | US | disclosed |
| US-3989723-A | ANTICOCCIDIAL, INSECTICIDES, ACARICIDES | ELI LILLY AND COMPANY (US) | 1976-11-02 | — | — | US | disclosed |
| US-3953474-A | ANTICOCCIDIAL, ANTIMICROBIAL | ELI LILLY AND COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192760-A1 | SYSTEMS AND METHODS FOR TYROSINASE-MEDIATED SITE-SPECIFIC PROTEIN CONJUGATION | TYR, TH, TDO2 | IDO1 439/4885ESR1 3257/4885ESR2 3883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.